Request Your Free Consultation

personal injury hotline


Interstitial cystitis is a terribly painful illness of the bladder. Elmiron was supposed to treat the symptoms of this condition, but after years on the market, scientists learned this drug also causes vision damage over time.

There is an active MDL against Janssen for failing to disclose this side effect. Pendleton Law has helped many victims in mass tort situations, including drugs. We can help you file your own lawsuit or help you join the MDL case so you can get compensation for what happened.

What Is Elmiron?

About one million people in the U.S. suffer from interstitial cystitis. Elmiron treats the symptoms, though the exact reason is unknown. The active ingredient, pentosan polysulfate sodium (PPS), builds up in the bladder to control symptoms.

Later, scientists found that people who have taken the drug for years suffer vision problems because of the buildup of the active ingredient. The drug label did not warn people about this risk until June 2020, but the drug has been on the market for years.

Discontinuing the drug does not reverse the damage, and victims have filed lawsuits against the manufacturer. We can work with medical experts to determine if Elmiron caused your vision loss. If so, you could be eligible for compensation.

For a Free Legal Consultation
Call The Personal Injury Lawyer Hotline.

What Is Pigmentary Maculopathy?

Pigmentary Maculopathy is a degenerative eye disease that affects the central area of the retina. When this area is damaged, you can lose central vision quickly. The longer you’ve taken the drug, the more likely you’ll have damage.

The macula is also responsible for seeing fine details and for nearly all of our color vision. If you are having trouble reading or have trouble with dim light and you’ve been taking Elmiron, see a doctor immediately for a checkup.

If you get a diagnosis, then you need to speak with one of our lawyers immediately to see if you qualify for filing an Elmiron lawsuit. As of this writing in September, 2022, these lawsuits are still getting litigated. 

 A March 2022 study showed that people using the drug for over three years had a 9.5-fold greater risk of maculopathy. The evidence is clear that victims will get compensation for vision damage from this drug. It’s just a matter of hashing out the details.

Let the Heavy Hitters® Take On Your Case 804-250-5050

Are There Eligibility Requirements?

To join the MDL, there are some things you’ll need to prove to show that you’re a member of the class. First, you’ll need to have taken the drug for at least two years and sought medical treatment for vision issues.

You’ll need to be diagnosed with a vision problem like pigmentary maculopathy by your doctor. Other vision problems like retinal maculopathy or macular degeneration can also qualify. Another requirement is that you get an eye disease diagnosis while taking Elmiron or within one year of stopping it.

Finally, your vision problems have to start on or after January 1, 2010. These requirements ensure you took the drug and make it more likely that the drug caused your eye damage.

Central Virginia's Top Rated Personal
Injury Lawyers 804-250-5050

Why Should I File a Lawsuit?

You can get compensation for the medical bills, lost wages, loss of quality of life, and other negative consequences from taking this drug. Also, by suing, you can bring greater awareness of this problem to the public.

Studies have been pointing toward a problem with Elmiron for years, but instead of acting out of caution, Jannsen did nothing until the evidence became too strong to ignore. Many people have since suffered from vision problems.

The victims in the lawsuit may get awarded punitive damages because of this negligent behavior, which means you could get more money beyond your actual damages in the case. But you cannot claim any compensation until you speak with one of our lawyers about starting a lawsuit.

Let Us Be The Heavy Hitters® For Your Case Speak To An Attorney Now

When Will the First Cases Start?

Preparation for Elmiron lawsuits has been happening for some time now, but none have been settled yet. The first bellwether trial is scheduled for around January 2023 in New Jersey. These early trials will help courts decide how to structure settlements throughout the nation and how much money victims could get.

Since it is so early, it may take years before the first payments come through. However, if you get in line early with your claim, the sooner you’ll receive a payment if we win the case. If the bellwether cases settle for a large amount, Janssen may offer a global settlement to pay victims.

If that happens, there will be a span of time where the courts decide how much to award people based on the severity of their injuries. After this, claims will start getting processed. Large drug litigation cases like this one often take a long time to resolve because there are so many plaintiffs.

Don’t Wait to Join the Elmiron Lawsuit

If you are currently taking Elmiron, speak with your doctor about finding an alternative treatment. The vision loss from this drug cannot be reversed. Also, get your eyes checked. If they find damage to your macula, you may be eligible to join the Elmiron lawsuit.

Find out your legal options in Williamsburg with a free consultation with The Pendleton Law Team. Call or email us to schedule your consultation. We look forward to helping you with your case.

The Pendleton Law Team Is Here For You 804-250-5050